Target cell defense prevents the development of diabetes after viral infection

Nature Immunology

Volumn 3, Issue 4, 2002, Pages 373-382

  Flodström, Malin ^a   Maday, Amy ^a   Balakrishna, Deepika ^a   Cleary, Mary Malo ^a   Yoshimura, Akihiko ^b   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; COXSACKIE VIRUS B4; DIABETES MELLITUS; DISEASE PREDISPOSITION; HOST; IMMUNITY; IMMUNOLOGICAL TOLERANCE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROPHYLAXIS; TARGET CELL; VIRUS INFECTION;

ANIMALS; CARRIER PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; DIABETES MELLITUS, TYPE 1; DNA-BINDING PROTEINS; DRUG RESISTANCE; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, TRANSGENIC; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATORS; VIRUS REPLICATION;

EID: 0036222240     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni771     Document Type: Article

References (86)

1. Enterovirus infections and insulin dependent diabetes mellitus - Evidence for causality
2. Environmental factors in the pathogenesis of type I diabetes mellitus
3. Type Ia diabetes induced by infection and immunization
4. Viruses, host responses, and autoimmunity
5. Viruses as triggers of autoimmunity: Facts and fantasies
6. Current cases in which epitope mimicry is considered as a component cause of autoimmune disease: Immune-mediated (type I) diabetes
7. Myocarditis and insulitis following coxsackie virus infection
8. Pancreatic islet-cell damage in children with fatal viral infections
9. A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM
10. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis
11. Coxsackie B4 virus induces short-term changes in the metabolic functions of mouse pancreatic islets in vitro
12. In vivo infection of mice with Coxsackie B4 virus induces long-term functional changes in pancreatic islets with minimal alteration in blood glucose
13. 2+ response to glucose in mouse β-cells infected with coxsackie B or Echo virus
14. Mechanisms of coxsackievirus-induced damage to human pancreatic β-cells
15. Acute onset of type I diabetes mellitus after severe echovirus 9 infection: Putative pathogenic pathways
16. Coxsackieviruses and diabetes
17. Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry
18. Coxsackievirus infection of the pancreas: Evaluation of receptor expression, pathogenesis, and immunopathology
19. A critical role for inducible nitric oxide synthase (NOS2) in host survival following Coxsackievirus B4 infection
20. Coxsackie virus: A review
21. T cells contribute to disease severity during coxsackievirus B4 infection
22. Multi-system coxsackievirus B-6 infection with findings suggestive of diabetes mellitus
23. Diabetes and Coxsackie virus B5 infection
24. L Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus
25. How cells respond to interferons
26. Interferons: Cell signalling, immune modulation, antiviral response and virus countermeasures
27. Interferon activation and innate immunity
28. The Stat family in cytokine signaling
29. Prolonged STATI activation is associated with interferon-γ priming for interleukin-I-induced inducible nitric-oxide synthase expression by islets of Langerhans
30. NIT-I, a pancreatic β-cell line established from a transgenic NOD/Lt mouse
31. The janus kinase inhibitor, Jab/SOCS-I, is an interferon-γ inducible gene and determines the sensitivity to interferons
32. Negative regulators of cytokine signaling
33. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-γ
34. SOCS-I protein prevents JAK/STAT-dependent inhibition of β cell insulin gene transcription and secretion in response to IFN-γ
35. Tissue culture of isolated human pancreatic islets infected with different strains of coxsackievirus B4: Assessment of virus replication and effects on islet morphology and insulin release
36. Immune defence in mice lacking type I and/or type II interferon receptors
37. Anatomical methods in cell death
38. Acceleration of type I diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets
39. Genetic control of autoimmune diabetes in the NOD mouse
40. Protection from lethal coxsackievirus-induced pancreatitis by expression of γ interferon
41. The NOD mouse
42. The nonobese diabetic scid mouse: Model for spontaneous thymomagenesis associated with immunodeficiency
43. Control of infections by NK cells
44. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
45. Immunomodulation of natural killer activity by polyribonucleotides
46. In vivo effect of anti-asialo GMI antibody on natural killer activity
47. +T cells as novel interleukin-12-responsive killer T cell precursors
48. Anti-asialo GMI eliminates both inflammatory process and cytotoxic T-cell function in the lymphocytic choriomeningitis adoptive transfer model
49. Differential expression of the ASGMI antigen on anti-reovirus and alloreactive cytotoxic T lymphocytes (CTL)
50. + T cells
51. +-like thymocytes in the NOD mouse
52. 1 hybrid mice injected with DBA/2 spleen cells
53. Murine natural killer cells limit coxsackievirus B3 replication
54. Coxsackievirus B4 infection of the mouse pancreas: The role of natural killer cells in the control of virus replication and resistance to infection
55. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5
56. Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors
57. The replication of certain Coxsackie B virus strains in CHO cells
58. Persistent infection of human pancreatic islets by coxsackievirus B is associated with α interferon synthesis in β cells
59. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
60. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses
61. Cytopathogenesis and inhibition of host gene expression by RNA viruses
62. Immunoreactive α-interferon in insulin-secreting β cells in type 1 diabetes mellitus
63. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V β usage, and cytokine profile
64. Interferon expression in the pancreases of patients with type 1 diabetes
65. Effect of human lymphoblastoid interferon on insulin synthesis and secretion in isolated human pancreatic islets
66. Effect of interferon and double-stranded RNA on B-cell function in mouse islets of Langerhans
67. Inhibitory effect of interferon on the production of insulin
68. Induction of type I diabetes by interferon-α in transgenic mice
69. Evidence from transgenic mice that interferon-β may be involved in the onset of diabetes mellitus
70. Interferon-α-induced endogenous superantigen. A model linking environment and autoimmunity
71. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies
72. A proposal of three distinct subtypes of type I diabetes mellitus based on clinical and pathological evidence
73. New concepts of the etiopathogenesis and treatment of insulin-dependent diabetes mellitus
74. Islet cell antibody seroconversion in children in temporally associated with enterovirus infections
75. Coxsackie B virus infection and β cell autoantibodies in newly diagnosed IDDM adult patients
76. Enterovirus infection as a risk factor for β-cell autoimmunity in a prospectively observed birth cohort: The Finnish Diabetes Prediction and Prevention Study
77. Restricted TCR V β gene expression and enterovirus infection in type I diabetes: A pilot study
78. Dendritic cells in autoimmune diseases
79. The role of enteroviral infections in the development of IDDM: Limitations of current approaches
80. A new protein containing an SH2 domain that inhibits JAK kinases
81. Structure and function of a new STAT-induced STAT inhibitor
82. A family of cytokine-inducible inhibitors of signalling
83. Interferon-γ-induced interferon regulatory factor-I (IRF-I) expression in rodent and human islet cells precedes nitric oxide production
84. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes